Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells

Biochemical Pharmacology

Volumn 65, Issue 3, 2003, Pages 329-338

  Harper, Jacquie L ^a   Camerini Otero, Carol S ^a   Li, An Hu ^a   Kim, Soon Ai ^a   Jacobson, Kenneth A ^a   Daly, John W ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Calcium channels; Capacitative calcium influx; Dihydropyridines; Inositol trisphosphate; Store operated calcium channels

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; FUNCTIONAL GROUP; INOSITOL TRISPHOSPHATE; METHYL GROUP; MRS 1844; MRS 1845; N METHYLNITRENDIPINE; N PROPARGYLNITRENDIPINE; PHENYL GROUP; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; METHYLATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

CALCIUM; CALCIUM CHANNELS; DIHYDROPYRIDINES; HL-60 CELLS; HUMANS; LEUKEMIA;

EID: 0037298749     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01488-0     Document Type: Article

References (20)

1. Berridge M.J. Capacitative calcium entry. Biochem. J. 312:1995;1-11.
2. Putney Jr JW. Capacitative calcium entry. Austin, TX: R.G. Landes Co.; 1997.
3. Putney J.W. Jr. TRP, inositol 1,4,5-trisphosphate receptors, and capacitative calcium entry. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14669-14671.
4. Krautwurst D., Hescheler J., Arndts D., Losel W., Hammer R., Shultz G. Novel potent inhibitors of receptor-activated nonselective calcium currents in HL60 cells. Mol. Pharmacol. 43:1993;655-659.
5. Daly J.W., Lueders J., Padgett W.L., Shin Y., Gusovsky F. Maitotoxin-elicited calcium influx in cultured cells. Effect of calcium-channel blockers. Biochem. Pharmacol. 50:1995;1187-1197.
6. 2+ channels. Cell Calcium. 19:1996;269-279.
7. Harper J.L., Daly J.W. Inhibitors of store-operated calcium channels: imidazoles, phenothiazines and other tricyclics. Drug Dev. Res. 47:1999;107-117.
8. 2+-entry antagonist LU 52396: its inhibitory activity depends on the activation state of the cells. Cell Calcium. 22:1997;91-97.
9. Harper J.L., Daly J.W. Effect of calmidazolium analogs on calcium influx in HL-60 cells. Biochem. Pharmacol. 60:2000;317-324.
10. Harper J.L., Shin Y., Daly J.W. Loperamide: a positive modulator for store-operated calcium channels? Proc. Natl. Acad. Sci. U.S.A. 94:1997;14912-14917.
11. Triggle D.J. Calcium channel drugs: structure-function relationships and selectivity of action. J. Cardiovasc. Pharmacol. 18(Suppl. 10):1991;S1-S6.
12. 2+ channel subtypes expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 291:1999;464-473.
13. 3 receptors. J. Med. Chem. 39:1996;2980-2989.
14. 3 adenosine receptor antagonists. J. Med. Chem. 40:1997;2596-2608.
15. 3 adenosine receptor antagonists. J. Med. Chem. 41:1998;3186-3201.
16. 2+ influx of U937 cells. FEBS Lett. 394:1996;159-164.
17. Hopf F.W., Reddy P., Hong J., Steinhardt R.A. A capacitative current in cultured skeletal muscle cells is mediated by the calcium-specific leak channel and inhibited by dihydropyridine compounds. J. Biol. Chem. 271:1996;22358-22367.
18. Fong P.Y., Turner P.R., Denetclaw W.F., Steinhardt R.A. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science. 250:1990;673-676.
19. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
20. 3 cells. Eur. J. Pharmacol. 376:1999;169-178.